Table 2. Binding Affinities of a Series of 1,2,4-Triazole Derivatives at the Human A1, A2A, and A3ARs Measured in Radioligand Binding Assays and Percent Inhibition of cAMP Accumulation in the Presence of 300 nM NECA in a Functional Assay for the A2BAR.
Ki (μM) or %
inhibition at 10 μMa |
|||||
---|---|---|---|---|---|
compd | R | A1 | A2A | A3 | A2B |
25 | CH3 | 18% | 43% | 0.3 ± 0.01 | 10% |
26 | CH2CH3 | 39% | 2.5 ± 0.6 | 0.3 ± 0.2 | 8% |
27 | (CH2)2CH3 | 0.8 ± 0.2 | 1.1 ± 0.2 | 0.2 ± 0.04 | 5% |
28 | 3.2 ± 0.7 | 5.9 ± 0.5 | 3.1 ± 0.7 | –7% | |
X | |||||
29 | H | 1.9 ± 0.3 | 0.4 ± 0.02 | 0.3 ± 0.2 | 72% |
30 | 4-CH3 | 1.3 ± 0.4 | 0.3 ± 0.1 | 0.1 ± 0.04 | 29% |
31 | 4-Cl | 31% | 2.8 ± 0.8 | 0.2 ± 0.1 | –2% |
32 | 2-OCH3 | 0.5 ± 0.1 | 0.2 ± 0.06 | 0.6 ± 0.2 | 16% |
33 | 22% | 0.2 ± 0.04 | 0.3 ± 0.2 | 10% | |
34 | 29% | 1.0 ± 0.2 | 1.0 ± 0.3 | –6% |
Measured in three independent experiments.